Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis (Q41416491)

From Wikidata
Jump to navigation Jump to search
scientific article published on 26 March 2009
edit
Language Label Description Also known as
English
Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis
scientific article published on 26 March 2009

    Statements

    Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit